UBS AG - OHR PHARMACEUTICAL INC ownership

OHR PHARMACEUTICAL INC's ticker is OHRP and the CUSIP is 67778H200. A total of 14 filers reported holding OHR PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of OHR PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2014$291,000
-67.3%
40,206
-57.0%
0.00%
Q2 2014$889,000
-4.9%
93,531
+36.2%
0.00%
-100.0%
Q1 2014$935,000
+6133.3%
68,659
+3627.4%
0.00%
Q4 2013$15,0000.0%1,842
-2.7%
0.00%
Q3 2013$15,000
+15.4%
1,893
+20.5%
0.00%
Q2 2013$13,0001,5710.00%
Other shareholders
OHR PHARMACEUTICAL INC shareholders Q4 2013
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 409,200$76,0000.06%
Leisure Capital Management 63,360$12,0000.01%
Bryn Mawr Capital Management, LLC 14,200$3,0000.00%
Virtu Financial LLC 189,095$35,0000.00%
WEDBUSH SECURITIES INC 75,000$14,0000.00%
MORGAN STANLEY 5,650$1,0000.00%
BRYN MAWR TRUST Co 10,000$2,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 78,800$15,0000.00%
BlackRock Inc. 413,137$77,0000.00%
Bank of New York Mellon Corp 34,472$6,0000.00%
View complete list of OHR PHARMACEUTICAL INC shareholders